Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 38

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 38
---
 | ​ | ​                             | ​ |  1,500,000 | ​ | ​ | ​ | ​          | ​ |  5.6 | ​ | ​ |
| Liminatus Members                 | ​ | ​ | ​                                      | ​ | 17,500,000 | ​ | ​ | ​ | ​          | ​ | 65.4 | ​ | ​ | ​ | ​                                        | ​ | 17,500,000 | ​ | ​ | ​ | ​          | ​ | 65.6 | ​ | ​ | ​ | ​                             | ​ | 17,500,000 | ​ | ​ | ​ | ​          | ​ | 65.8 | ​ | ​ |
| Total Shares                      | ​ | ​ | ​                                      | ​ | 26,774,477 | ​ | ​ | ​ | ​          | ​ | 100% | ​ | ​ | ​ | ​                                        | ​ | 26,687,238 | ​ | ​ | ​ | ​          | ​ | 100% | ​ | ​ | ​ | ​                             | ​ | 26,600,000 | ​ | ​ | ​ | ​          | ​ | 100% | ​ | ​ |

Percentages may not add to 100% due to rounding. (1) Based on an aggregate of 17,500,000 shares of ParentCo Common Stock, which will be issued as consideration in the Transactions; and does not take into account the dilutive effects of: (i) the exercise of 7,735,555 ParentCo Warrants to purchase ParentCo’s common stock that will be outstanding following the Business Combination, or (ii) any equity awards that may be issued under the proposed Incentive Plan following the Business Combination. If the actual facts are different than these assumptions (which is likely), the ownership percentages held by each of our existing stockholders, Sponsor, Iris’s independent directors, Cantor and the Liminatus Members will be different. (2) Assumes that no additional stockholders exercise redemption rights. (3) Assumes that an additional 50%, or 87,238 shares of Iris Class A Common Stock are redeemed for cash. (4) Number of shares determined based on a price of $10.00 per share. Such price is subject to adjustment based on the five day volume-weighted average price prior to the filing of a resale registration statement covering such shares. Shares to be Issued on a Fully-diluted Basis

|